# Aqrose

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aqrose

- Industry: Software
- Headquarters: Beijing, China
- Website: www.aqrose.com
- Total disclosed funding: $39M
- Latest round: Series B (Apr 9, 2021)
- Investors on record: 8

## About

Aqrose, based in Beijing, China, is a technology company that provides advanced industrial AI vision solutions focused on defect detection and quality control in manufacturing processes.Founded in 2017 by Yao Huang, Aqrose specializes in AI-driven vision technology. The company has not undergone any significant pivots and operates without known subsidiaries. Located in Beijing, China, it has completed five investment deals, with the latest being a Series B round in April 2021, securing USD 20.00 mn from investors including Xiang He Capital and DCM.Aqrose Technology Co., Ltd. specializes in providing advanced industrial AI vision solutions that address critical challenges in defect detection, classification, and recognition. Their core product offerings include the AIDI (Industrial AI Vision Algorithm Platform) and AIDG (Artificial Intelligent Defect Generator), designed to enhance quality control processes by leveraging AI technology. These solutions allow for high-fidelity defect image generation, real-time assembly verification, and efficient classification of product defects, ultimately facilitating improved yield and process traceability. The company's innovations are geared towards industries requiring rigorous quality assurance, with applications spanning manufacturing, assembly, and agricultural sectors. Aqrose serves a diverse client base globally, focusing on markets that demand high precision in production quality, including Asia, North America, and Europe.Aqrose Technology generates revenue through a structured business model that typically includes software licensing and subscription services for its flagship products, AIDI and AIDG. The company engages in B2B transactions, partnering with manufacturers and assembly facilities that require advanced vision technology for quality control. Customers utilize these solutions under a subscription model, ensuring ongoing access to software updates and support. The pricing structure is tailored to accommodate varying client needs, with specific plans reflecting the complexity and scale of the implementation. These transactions emphasize long-term partnerships that enhance product quality and operational efficiency, reinforcing Aqrose's position in the AI vision technology market.Aqrose plans to leverage its recent funding from the Series B round in April 2021 to support the development of new products and expand its market reach. The company is focusing on launching additional AI vision solutions tailored for manufacturing industries, with specific timelines yet to be finalized. Furthermore, Aqrose aims to penetrate new geographic markets, particularly in North America and Europe, by the end of 2022. The funding will also facilitate enhanced R&D efforts to innovate and improve its existing product offerings.

## Funding rounds

- Series B, Apr 9, 2021 — Vision Knight Capital, Xiang He Capital
- Series B, Nov 12, 2020, $20M — DCM, Legend Capital, Xiang He Capital
- Series A, Feb 28, 2019, $10M — DCM, Legend Capital, Baidu Ventures
- Series A, Jan 18, 2018, $8M — DCM, Baidu Ventures, Powercloud, Long Capital, Innoangel Fund
- Angel, Mar 1, 2017, $1.4M — Powercloud, Innoangel Fund

## Investors

- Powercloud (https://capitalatlas.ai/funds/powercloud) — Angel, Series A
- Innoangel Fund (https://capitalatlas.ai/funds/innoangel-fund) — Angel, Series A
- DCM (https://capitalatlas.ai/funds/dcm) — Series A, Series B
- Baidu Ventures (https://capitalatlas.ai/funds/baidu-ventures) — Series A
- Long Capital (https://capitalatlas.ai/funds/long-capital) — Series A
- Legend Capital — Series A, Series B
- Xiang He Capital (https://capitalatlas.ai/funds/xiang-he-capital) — Series B
- Vision Knight Capital (https://capitalatlas.ai/funds/vision-knight-capital) — Series B